H.R. 3988, The Generic Drug and Biosimilar User Fee Act of 2012
- This item is from the 112th Congress (2011-2012) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.
H.R. 3988 would amend the Federal Food, Drug, and Cosmetic Act to establish user-fee programs for generic drugs and biosimilars.